Skip to main content

Animations

MJFF Publications

1801 - 1810 of 8404 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Genomics transformer for diagnosing Parkinson's disease
    Journal Name: 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/bhi56158.2022.9926815
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
    Journal Name: Journal of Parkinson's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-223245
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Neuronal Presentation of Antigen and Its Possible Role in Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-223153
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Blood based biomarkers for movement disorders
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/ane.13700
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: LRRK2 phosphorylation of Rab GTPases in Parkinson's disease
    Journal Name: FEBS Letters
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/1873-3468.14492
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolites
    Journal Name: Journal of Cerebral Blood Flow & Metabolism
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/0271678x221126830
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-022-05963-x
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Effect Modification between Genes and Environment and Parkinson's Disease Risk
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26467
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Glycolysis: The Next Big Breakthrough in Parkinson’s Disease
    Journal Name: Neurotoxicity Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12640-022-00579-3
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Relationship between Substantia Nigra Neuromelanin Imaging and Dual Alpha-Synuclein Labeling of Labial Minor in Salivary Glands in Isolated Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/genes13101715
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.